I am a healthcare futurist dedicated to identifying opportunities to enhance patient care delivery, develop new business models, and generate revenue streams. I have successfully designed and established innovation structures to drive key strategic initiatives at Genmab, Novo Nordisk, and GSK resulting in significant brand and revenue growth.Earlier in my career, I spent 12 years at GSK translating market and policy changes into business opportunities. This work required a well-rounded knowledge of many different verticals including public policy. Public Policy touches all levers of commercialization including Customer Marketing, Brand Marketing, Market Access, Account Management, and Sales. The impact of policy changes is often overlooked when assessing go-to-market opportunities. The experience of meeting with regulatory agencies and various policy organizations provided me with a unique insight into what ultimately drives changes in both the public and private healthcare markets.As a futurist, I am currently focused on developing new, data-driven, capabilities to create a sustainable commercial model that delivers a differentiated experience for customers. To be successful, I monitor market phenomena and industry trends and leverage data to generate insights and create thoughtful hypotheses on where Genmab should focus and invest.Key Accomplishments include:► Built Novo Nordisk US Commercial Innovation Unit -- Designed and received funding for the Novo Nordisk Innovation arm for Patient Support, Care Delivery, and Reimbursement programs. Successfully launched 3 pilot programs in Behavioral Health and Digital Therapeutics (obesity market), Dynamic Co-Pay Offsets (diabetes market), and an Integrated Care Delivery Platform (obesity market).► Developed the strategic approach to advance GSK’s Advair revenue growth -- Realized significant revenue increase in the $2B hospital and health system market by creating and implementing programs to address patient fulfillment dropoff.► Key Contributor to GSK’s Comprehensive Medication Management Public Policy Program -- Collaborated with Community Care of North Carolina (CCNC) to build predictive models to identify patients at risk for drug therapy problems and care logistics engine to align appropriate interventions.Healthcare is ripe for transformation. I believe that through multi-stakeholder collaboration we can implement new approaches, provide better value to patients, reduce costs, and deliver better outcomes.